lung cancer

Sydney, Australia, September 1, 2026 Kazia Therapeutics Limited has reported new preclinical and translational findings suggesting that its investigational...

Hong Kong, Shanghai, China, and Florham Park, New Jersey, August 31, 2026 HUTCHMED (China) Limited has announced positive high-level...

SAN ANTONIO, September 1, 2026 bioAffinity Technologies, Inc. is advancing the potential use of its noninvasive CyPath® Lung test...

Hong Kong, Shanghai & Florham Park, NJ – August 31, 2026 HUTCHMED (China) Limited announced positive high-level results from...

North Chicago, Illinois, USA, August 21, 2026 AbbVie has announced new clinical, translational and real-world research findings that will...

Redwood City, California, August 20, 2026 Galvanize Therapeutics, Inc. has announced new peer-reviewed evidence suggesting that its Aliya® pulsed...

Menlo Park, California, August 20, 2026 Maverix Medical has announced that the U.S. Food and Drug Administration (FDA) granted...

MAINZ, Germany, August 20, 2026 BioNTech SE is set to highlight major progress across its lung cancer clinical development...

NANJING, China, August 20, 2026 Leads Biolabs announced that the full abstract for its Phase II study of LBL-024...

Santa Clara, California, August 17, 2026 Johnson & Johnson announced U.S. 510(k) regulatory clearance for MONARCH™ QUEST 3, the...